A review of Cabenuva®, an antiretroviral agent for HIV.
The Canadian Breakpoint di Dr. Rupeena Purewal
S1 · E4
22 feb 2022
36:02
Note sull'episodio
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.
Parole chiave
cabenuva